Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The interest coverage ratio is -23.00x as of the fiscal period ended Saturday, June 30, 2018.
Reported quarterly interest coverage; no daily interpolation.
Limited quarterly history available
Interest Coverage needs at least three reported quarters before a meaningful chart is shown.
INTEREST COVERAGE RATIO
-23.00x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
-257.13%
vs the sector median at left
Vir Biotechnology, Inc.
Market Cap
$1.96B
Interest Coverage Ratio
-23.00x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.95B
Interest Coverage Ratio
-1.02x
TTM Avg
0.38x
3Y Avg
0.38x
5Y Avg
0.21x
Market Cap
$1.97B
Interest Coverage Ratio
371.93x
TTM Avg
1006.04x
3Y Avg
1006.04x
5Y Avg
1006.04x
Market Cap
$1.98B
Interest Coverage Ratio
-0.33x
TTM Avg
467.98x
3Y Avg
502.49x
5Y Avg
502.49x
Market Cap
$1.94B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.92B
Interest Coverage Ratio
-1.54x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.02B
Interest Coverage Ratio
24.23x
TTM Avg
24.23x
3Y Avg
24.23x
5Y Avg
24.23x
Market Cap
$2.02B
Interest Coverage Ratio
-3.69x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.89B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vir Biotechnology, Inc. (VIR) | $1.96B | -23.00x | N/A | N/A | N/A |
| AxoGen, Inc. (AXGN)vs › | $1.95B | -1.02x | 0.38x | 0.38x | 0.21x |
| Inspire Medical Systems, Inc. (INSP)vs › | $1.97B | 371.93x | 1006.04x | 1006.04x | 1006.04x |
| Fortrea Holdings Inc. (FTRE)vs › | $1.98B | -0.33x | 467.98x | 502.49x | 502.49x |
| Mineralys Therapeutics, Inc. (MLYS)vs › | $1.94B | N/A | N/A | N/A | N/A |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.92B | -1.54x | N/A | N/A | N/A |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.02B | 24.23x | 24.23x | 24.23x | 24.23x |
| UroGen Pharma Ltd. (URGN)vs › | $2.02B | -3.69x | N/A | N/A | N/A |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.89B | N/A | N/A | N/A | N/A |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.02B | 4.32x | 4.32x | 4.32x | 4.32x |
Interest Coverage
-23.0x
Debt/Equity
0.09
Current Ratio
6.04
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2018-06-30 | -23.00x |
